Moleculin Biotech, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Moleculin Biotech, Inc. (MBRX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $7.99 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-13
- Moleculin Biotech, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $7.99M.
- Moleculin Biotech, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $4.66M.
- Moleculin Biotech, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $375.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|
| 2025-03-31 | $7.99M 10-Q · filed 2026-08-13 | ||
| 2024-09-30 | $4.66M 10-Q · filed 2025-11-13 | ||
| 2016-12-31 | $375.00K 10-K · filed 2018-03-28 | $374.76K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |